Efficacy of an orlistat-resveratrol combination for weight loss in subjects with obesity: A randomized controlled trial.

Objective: To evaluate the efficacy of an orlistat-resveratrol (O-R) combination in subjects with obesity over a 6-month period.

Methods: This study was a double-blind, parallel, randomized controlled clinical trial. Patients fulfilling the selection criteria (age from 20 to 60 years and body mass index (BMI) ≥30 and ≤39.